A new intravenous calcium channel blocker option to treat acute elevations in blood pressure

Journal of Clinical Hypertension

Volumn 11, Issue 7, 2009, Pages 386-387

  Cohen, Debbie L ^a   Townsend, Raymond R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLEVIDIPINE; NICARDIPINE; PLACEBO;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; DRUG ADMINISTRATION ROUTE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SIDE EFFECT; VASODILATATION;

ACUTE DISEASE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; NICARDIPINE; PYRIDINES; TREATMENT OUTCOME;

EID: 67650676814     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00132.x     Document Type: Article

References (10)

1. Aronson S, Dyke CM, Stierer KA, et al The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110-1121.
2. Varon J. Treatment of acute severe hypertension: Current and newer agents. Drugs. 2008;68:283-297.
3. Marik PE, Varon J. Hypertensive crises: Challenges and management. Chest. 2007;131:1949-1962.
4. Kieler-Jensen N, Jolin-Mellgard A, Nordlander M, et al Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand. 2000;44:186-193.
5. Ericsson H, Bredberg U, Eriksson U, et al. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology. 2000;92:993-1001.
6. Nordlander M, Sjoquist PO, Ericsson H, et al Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004;22:227-250.
7. Zhang JG, Dehal SS, Ho T, et al Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81. Drug Metab Dispos. 2006;34:734-737.
8. Bailey JM, Lu W, Levy JH, et al Clevidipine in adult cardiac surgical patients: A dose-finding study. Anesthesiology. 2002;96:1086-1094.
9. Pollack CV, Varon J, Garrison NA, et al Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53:329-338.
10. Singla N, Warltier DC, Gandhi SD, et.al. Treatment of acute postoperative hypertension in cardiac surgery patients: An efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2008; 107: 59-67.